Everett Hits Rival Acella With 2 Prenatal Patent Suits

Law360, New York (June 7, 2013, 6:10 PM EDT) -- Everett Laboratories Inc. sued Acella Pharmaceuticals LLC on Wednesday and Thursday in New Jersey federal court, accusing it of infringing three patents for prenatal nutritional supplements.

New Jersey-based Everett claims in the lawsuits that the prescription prenatal supplements "Choice-OB+DHA" and "PNV-OB with DHA" marketed by Acella are identical copies of — and infringe patents for — supplements marketed by Everett as "Select-OB+DHA" and "Vitafol-OB+DHA."

Because Acella sells its supplements for a lower price, it threatens to cannibalize Everett's market share, the complaints say. Acella's version of the supplement...
To view the full article, register now.